Contact us

Commercial CDMO Companies
Commercial Contract Manufacturing Services

Your Trusted Partners for Commercial Contract Manufacturing and Development

Showing 144 facilities
Laboratorio REIG JOFRE, SA (TOLEDO PLANT)
Spain

Laboratorio REIG JOFRE, SA (TOLEDO PLANT)

LABORATORIO REIG JOFRE SA

Betalactam antibiotics (FDF) development and manufacturing state-of-the-art facilities.

MARKETS: EMA (EU), ANVISA (Brazil), ISP (Chile), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), INVIMA (Colombia), SFDA (Saudi Arabia), TGA (Australia)

REGION: APAC, MENA, LATAM, Europe, North America

COMPLIANCE: DIGEMID, ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority), INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

BATCH SIZE: Large, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (J) Antiinfectives for systemic use

CONTROLLED SUBSTANCES: Lowest potential for abuse

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Laboratorios Grifols | Barcelona Plant
Spain

Laboratorios Grifols | Barcelona Plant

Grifols International

Sterile manufacturing solutions (small molecules) in flexible bags and vials.

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (M) Musculoskeletal system, (N) Nervous system, (A) Digestive tract and metabolism

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Laboratorio REIG JOFRE, SA (BARCELONA PLANT)
Spain

Laboratorio REIG JOFRE, SA (BARCELONA PLANT)

LABORATORIO REIG JOFRE SA

Injectable (lyo and liquid) and Liquid manufacturing facilities.

BSL (Biological Safety Level): 3, 1, 2

MARKETS: EMA (EU), PMDA (Japan), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MHRA (UK), INVIMA (Colombia), MFDS (South Korea), TGA (Australia)

REGION: Europe

BATCH SIZE: Large, Medium

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (R) Respiratory system, (A) Digestive tract and metabolism

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

COMPLIANCE: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), ECOVADIS, INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

VIVEbiotech
Spain

VIVEbiotech

VIVEbiotech

Your leading GMP-certified CDMO exclusively dedicated to the production of lentiviral vectors.

MARKETS: EMA (EU), FDA (USA), MHRA (UK)

REGION: Europe

COMPLIANCE: FDA (cGMP), French Service-Public (CIR), EMA (EU GMP), MHRA (UK GMP)

BATCH SIZE: Large, Small, Medium

USE: Human

BSL (Biological Safety Level): 1, 2

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

CATEGORY / PRODUCT: BIOLOGICS

Viswa Laboratories Pvt Ltd
India

Viswa Laboratories Pvt Ltd

Viswa Laboratories Private Limited

CRAMS/CDMO, APIs, Intermediates and specialty chemicals.

MARKETS: EMA (EU), NMPA (China), ANVISA (Brazil), Russian Health Authorities, CDSCO (India)

REGION: APAC

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (R) Respiratory system

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

COMPLIANCE: World Health Organization (GMP / HACCP)

Pharmaron API Commercial Synthesis Shaoxing (China)
China

Pharmaron API Commercial Synthesis Shaoxing (China)

Pharmaron

Commercial API Small Molecules /Peptides Synthesis.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MARKETS: NMPA (China), FDA (USA)

REGION: APAC

COMPLIANCE: FDA (cGMP), ISO, NMPA (China GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

Pharmaron API Commercial Synthesis Cramlington (UK)
United Kingdom

Pharmaron API Commercial Synthesis Cramlington (UK)

Pharmaron

Commercial API Small Molecules Synthesis.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)

REGION: Europe

COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

Pharmaron API Commercial Synthesis Coventry (US)
United States

Pharmaron API Commercial Synthesis Coventry (US)

Pharmaron

Commercial API Small Molecules Synthesis.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea), TGA (Australia)

COMPLIANCE: FDA (cGMP), ISO, ECOVADIS

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

REGION: North America

HIPRA BIOTECH SERVICES | Amer
Spain

HIPRA BIOTECH SERVICES | Amer

HIPRA Biotech Services

End-to-end internal capabilities from cell line development to commercial manufacturing.

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: BIOLOGICS, FDF / DRUG PRODUCTS

BAG Health Care
Germany

BAG Health Care

BAG Health Care GmbH

Parenteral F&F provider for vials in small to mid sized batches.

MARKETS: EMA (EU), MHRA (UK), TGA (Australia)

REGION: Europe

USE: Human, Veterinary

BSL (Biological Safety Level): 1

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

BATCH SIZE: Small, Medium

COMPLIANCE: EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Lifecore Injectables CDMO
United States

Lifecore Injectables CDMO

Lifecore Biomedical

CDMO that manufactures clinical & commercial sterile injectable drug products.

BSL (Biological Safety Level): 3, 1, 2

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

COMPLIANCE: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CONTROLLED SUBSTANCES: Lowest potential for abuse

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

REGION: North America

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

53Biologics Production Plant
Spain

53Biologics Production Plant

53Biologics

53Biologics is a Spanish CDMO specialized in decoding the production of biologicals, from DNA to proteins.

MARKETS: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

CATEGORY / PRODUCT: BIOLOGICS

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+71 more facilities

Create free account

Bringing a pharmaceutical product to market requires a partner that can deliver consistent quality at scale. That’s where commercial CDMOs come in. These specialized providers offer the infrastructure, expertise, and regulatory readiness to handle full-scale production, packaging, and distribution—helping you transition seamlessly from development to commercialization.

Whether you’re launching a new drug or scaling up an existing one, commercial contract manufacturing services ensure reliable supply, regulatory compliance, and cost efficiency across global markets.

How to Choose a Commercial Contract Manufacturing Partner

Selecting the right commercial CDMO is crucial for product success. Beyond technical capabilities, look for a partner with:

Executing global market launches via Proven experience: In commercial-scale manufacturing and global launches.

Meeting international health standards through a Regulatory track record: With agencies like the FDA, EMA, and others.

Ensuring continuous product availability via Robust supply chain management: Including sourcing, inventory control, and distribution.

Accommodating fluctuating market demand through Flexible capacity: To support demand fluctuations and future growth.

Maintaining stringent compliance with a Commitment to quality: Through rigorous GMP compliance and continuous improvement systems.

A successful commercial partnership is built on transparency, strategic alignment, and shared long-term goals.

Key Services Offered by Commercial CDMOs

Delivering high-volume drug supply through Full-Scale GMP Manufacturing: High-volume commercial production across a range of dosage forms, including solid, liquid, sterile, and specialty formulations.

Validating late-stage drug processes via Technology Transfer & Process Validation: Transfer of late-stage processes into commercial environments with full validation and documentation.

Securing regulatory-compliant market packaging through Commercial Packaging & Serialization: Blistering, bottling, labeling, and serialization services for regulatory-compliant supply.

Ensuring ongoing commercial batch quality via Stability & Release Testing: Ongoing quality control and ICH-compliant stability programs for commercial batches.

Managing global drug distribution through Global Logistics & Supply Chain Coordination: Warehousing, inventory management, and worldwide distribution solutions.

Advantages of Partnering with a Commercial CDMO

Streamlining technical transfers for an Accelerated Time to Market: Streamlined tech transfer and readiness to launch at scale.

Navigating complex health authority audits for Regulatory Confidence: Commercial CDMOs experienced in audits and submissions for multiple regulatory bodies worldwide.

Driving cost control via Operational Efficiency: Lean manufacturing practices and automation drive cost control and consistency.

Ensuring batch-to-batch consistency for Risk Mitigation: Integrated quality systems reduce supply chain disruptions and ensure product reliability.

Adjusting production outputs to market demand via Scalability: Ability to adjust batch sizes and production schedules based on market demand.

Commercial Manufacturing CDMO Companies

Some of the top commercial CDMO companies:

Actylis: CDMO specialized in Chemical Process Discovery, Development, cGMP, and Commerical Manufacturing Services. [See CDMO profile]

Aenova: CDMO for high volume manufacturing of conventional solids. [See CDMO profile]

CDM Lavoisier: Commercial manufacturing of glass ampoules, glass vials and plastic (BFS) ampoules. [See CDMO profile]

Cambrex: CDMO that develops and manufactures proprietary products (generic APIs) and provides contract manufacturing services for intermediates and custom APIs at commercial scale. [See CDMO profile]

Lannett CDMO: Lannett’s main manufacturing site includes capabilities for Oral Solid Dose (OSD) and Liquids. [See CDMO profile]

Cenexi: CDMO specializing in the commercial production of sterile highly potent injectables, mainly against cancer. [See CDMO profile]

Viswa Laboratories: CRAMS/CDMO, APIs, Intermediates and specialty chemicals. [See CDMO profile]

Pharmaloop: Fully integrated commercial CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets. [See CDMO profile]

FAES FARMA: Developer and manufacturer of human medicinal products at commercial scale. [See CDMO profile]

Grifols: Sterile commercial manufacturing solutions (small molecules) in flexible bags and vials. [See CDMO profile]

Pharmaron: Small molecule (RSM/APIs) commercial facility. [See CDMO profile]

VIVUNT PHARMA: CDMO for sterile oncology drugs. [See CDMO profile]

Shilpa Biologicals: CDMO supporting Process Development, Gene to Cell Line Development to GMP to Formulation Development, Analytical Development, Drug Substance Commercial Manufacturing, Drug Product, Fill-Finish and Packaging. [See CDMO profile]

Reig Jofre: Betalactam antibiotics (FDF) development and manufacturing with state-of-the-art facilities. [See CDMO profile]

Mabion: Fully integrated CDMO offering development and GMP manufacturing of biotherapeutics, including commercial manufacturing. [See CDMO profile]

53Biologics: CDMO specialized in decoding biologics production, from DNA to proteins, from preclinical to cGMP commercial manufacturing. [See CDMO profile]

VIVEbiotech: Leading GMP-certified CDMO exclusively dedicated to lentiviral vector production. [See CDMO profile]

HIPRA BIOTECH SERVICES: End-to-end internal capabilities from cell line development to commercial manufacturing. [See CDMO profile]

Skyepharma: Development and delivery of oral technologies serving the global pharmaceutical, biotech and consumer health industries. [See CDMO profile]

Ophtapharm, a Sentiss Company: Ophthalmic and Otic – solutions, suspensions, emulsions, ointments and gels – FDA Approved facility. [See CDMO profile]

CARBOGEN AMCIS: Highly potent APIs development and small-scale cGMP production including chromatography and lyophilization. [See CDMO profile]

Sichuan Huiyu Pharmaceuticals Co., Ltd: Manufacturing and Formulation sites; R&D supporting API and FDF development. [See CDMO profile]

AdhexPharma SAS: CDMO for transdermal patches and oromucosal films. [See CDMO profile]

Apeloa Pharmaceutical Co., Ltd: Development and manufacturing services for APIs, intermediates and registered starting materials. [See CDMO profile]

Glatt Pharmaceutical Services GmbH Co. & KG: cGMP CDMO for end-to-end services in complex oral solid dosage forms. [See CDMO profile]

Lukas Heil-Betriebsstätte: High-performance GMP facility for sterile and aseptic liquids, especially glass ampoules. [See CDMO profile]

Darnytsia Kyiv: CMO with advanced facilities, stringent quality control and expert staff. [See CDMO profile]

Adragos Pharma: Over 100 years of experience delivering first-class service and customer-focused manufacturing. [See CDMO profile]

Cellex Cell Professionals: CGT CDMO with Cell Manufacturing Plant and Collection Center for starting materials. [See CDMO profile]

BAG Health Care: Parenteral F&F provider for vials in small to mid-sized batches and investigational products. [See CDMO profile]

Ascendia Pharmaceutical Solutions: GMP-certified CDMO for sterile and non-sterile manufacturing, formulation development and analytical testing. [See CDMO profile]

MENADIONA S.L: APIs, intermediates and fine chemicals, specialized in scaling R&D into fully cGMP-compliant processes. [See CDMO profile]

i+Med: Developer and manufacturer of new drug products with controlled release technologies. [See CDMO profile]

Liof Pharma S.L.U.: CDMO for aseptic manufacturing and lyophilization of biologics and injectables. [See CDMO profile]

Content Group: Tubilux Pharma: registered office and manufacturing facility. [See CDMO profile]

ChemCon GmbH: Contract development and manufacturing partner for APIs and fine chemicals, specializing in cGMP scale-up. [See CDMO profile]

Sidefarma: Manufacturer of small and medium-sized batches for global regulated markets under EU quality standards. [See CDMO profile]

TRADICHEM INDUSTRIAL SERVICES: HIPERING® Technology – the gateway for lean manufacturing. [See CDMO profile]

Related Information

You may also be interested in:

FDF CDMO Services | Finished Dosage Forms Contract Manufacturing

Biologics CDMO Companies | Biopharmaceutical Contract Manufacturing

Chemical CMO companies | Custom Synthesis and Chemical CMO Solutions

Investigational Product CDMO Companies | Clinical Contract Manufacturing Services

Human Drugs CDMO Companies | Human Medicinal Products Contract Manufacturing Services

Small Batch Size CDMO Companies | Small Batch Size Contract Manufacturing Services

Medium Batch Size CDMO Companies | Medium Batch Size Contract Manufacturing Services

Large Batch Size CDMO Companies | Large Batch Size Contract Manufacturing Services

Let MAI CDMO Help You Find the Right Commercial Manufacturing Partner

Choosing the right commercial CDMO is a strategic decision that impacts your product’s success on the market. MAI CDMO connects you with experienced commercial contract manufacturing partners tailored to your product, scale, and regulatory needs.

We work closely with you to understand your goals and identify commercial CDMOs with the technical capabilities, capacity, and compliance record to meet them.

Contact us today to explore commercial CDMO solutions and ensure your product reaches patients—on time, at scale, and with uncompromised quality.